France’s Medical Cannabis Trial: 3% Serious Adverse Events in 3,164 Patients Over Three Years
The medical cannabis safety adverse drug reactions study in France tracked 3,164 patients over three years. It found 3% experienced serious adverse drug reactions, mainly neurological, gastrointestinal, and psychiatric. This observational study provides…
Association of Multimodal Cannabis Use with Adverse Events among Adolescents and Young Adults.
The ways cannabis is consumed, or modes of use, have increased and diversified in recent years, especially among young people. Associations of multimodal can...
CBD Gummies Hallucinations: What the Evidence Actually Shows
Reports of hallucinations linked to CBD products highlight the importance of CBD product safety adverse events. These events often stem from contamination or dosing errors rather than CBD itself. Understanding these risks is crucial for patient safety…
Canada’s Cannabis Safety Surveillance System: What Six Years of Adverse Reaction Reports Reveal
Cannabis safety pharmacovigilance in Canada from 2018 to 2024 highlights important patterns in adverse reaction reports. Most reports involve older adults using cannabis medically, with extracts frequently implicated. This surveillance data provides…
New Funding Enables Psychedelic Therapy Safety Tracking in Colorado
New funding enables psychedelic therapy safety tracking in Colorado to monitor adverse events and usage patterns. This initiative provides critical real-world data for patient safety. It supports clinical research and informs therapeutic guidelines.
These 5 N.J. Smoke Shops Ordered to Shut Down Amid Cannabis Crackdown
Unregulated cannabis products risks are a major concern as five N.J. smoke shops were ordered to shut down in a city crackdown. These unauthorized shops pose significant patient safety risks due to lack of quality control. Patients should be advised to…
Cannabinoid Safety in Adults Over 50: Meta-Analysis Review
This meta-analysis highlights cannabinoid safety older adults, showing low adverse event rates for THC and CBD alone. Combination THC:CBD products showed higher withdrawal rates. The study emphasizes cautious use and the need for controlled trials in…
Cannabis Medicines Cause Dose-Dependent Side Effects in Older Adults, Meta-Analysis Finds
Dose-dependent side effects cannabinoids cause include dizziness, dry mouth, and coordination difficulties in older adults. This 2024 meta-analysis highlights the importance of cautious dosing. Understanding these risks helps clinicians manage…
Investigating Medicinal Cannabis for Muscle Spasticity and Spasms
This muscle spasticity cannabis study evaluates the effectiveness and adverse events of medicinal cannabis in patients with muscle spasticity or spasms. CBD-only products showed meaningful improvements in sleep disturbance, fatigue, and pain interference…
Medical Cannabis Use in France: An Observational Safety Study Based on the RECANN Registry and the Pharmacovigilance/Addictovigilance System From 2021 to 2024.
This medical cannabis safety study France analyzes adverse events from the RECANN registry between 2021 and 2024. It provides key insights into neurological, gastrointestinal, and psychiatric side effects. The study supports informed clinical decisions…